Assurance qualité de l’essai randomisé de phase II du groupe d’oncologie radiothérapie tête et cou (Gortec) 2004–2014 comparant irradiation stéréotaxique et chimiothérapie et irradiation stéréotaxiques pour des cancers ORL oligométastatiques

J. Thariat; J. Castelli; C. Florescu; M. Minsat; S. Heymann; M. Rives; A. Serre; A. Goineau; C. Michel; J. Bourhis; X. Sun

doi:10.1016/j.canrad.2016.08.015

Assurance qualité de l’essai randomisé de phase II du groupe d’oncologie radiothérapie tête et cou (Gortec) 2004–2014 comparant irradiation stéréotaxique et chimiothérapie et irradiation stéréotaxiques pour des cancers ORL oligométastatiques

Cancer/Radiothérapie ◽

10.1016/j.canrad.2016.08.015 ◽

2016 ◽

Vol 20 (6-7) ◽

pp. 718

Author(s):

J. Thariat ◽

J. Castelli ◽

C. Florescu ◽

M. Minsat ◽

S. Heymann ◽

...

Keyword(s):

Phase Ii ◽

Assurance Qualité ◽

Cancers Orl ◽

Tête Et Cou

Download Full-text

Phase II study of safety, efficacy and pharmacokinetics of BXT-51072 in patients with mild-moderately active ulcerative colitis

Gastroenterology ◽

10.1016/s0016-5085(01)81390-1 ◽

2001 ◽

Vol 120 (5) ◽

pp. A280-A280

Author(s):

S HANAUER ◽

P MINER ◽

A KESHAVARZIAN ◽

E MORRIS ◽

B SALZBERG ◽

...

Keyword(s):

Ulcerative Colitis ◽

Phase Ii ◽

Phase Ii Study ◽

Active Ulcerative Colitis

Download Full-text

1400: A Randomized Phase II Trial Evaluating the Importance of Early Erectile Dysfunction Rehabilitation and Unilateral Autologous Sural Nerve Grafting in Patients Undergoing a Unilateral Cavernous Nerve Sparing Radical Prostatectomy for Clinically localized PR

The Journal of Urology ◽

10.1016/s0022-5347(18)31601-x ◽

2007 ◽

Vol 177 (4S) ◽

pp. 461-461 ◽

Cited By ~ 1

Author(s):

Christopher G. Wood ◽

David Chang ◽

Run Wang ◽

Yu Shen ◽

Curtis A. Pettaway ◽

...

Keyword(s):

Erectile Dysfunction ◽

Radical Prostatectomy ◽

Phase Ii ◽

Sural Nerve ◽

Phase Ii Trial ◽

Nerve Sparing ◽

Nerve Grafting ◽

Cavernous Nerve ◽

Randomized Phase Ii

Download Full-text

1142: Multicenter Phase II Study of Combined Neoadjuvant Docetaxel and Hormone Therapy Prior to Radical Prostatectomy for Patients with High Risk Localized Prostate Cancer: Pathologic Outcomes and 3-Year Follow-Up Analyses

The Journal of Urology ◽

10.1016/s0022-5347(18)31356-9 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 377-377

Author(s):

Martin E. Gleave ◽

Kim Chi ◽

Joseph L. Chin ◽

Eric Winquist ◽

Laurence H. Klotz ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Hormone Therapy ◽

Phase Ii ◽

Phase Ii Study ◽

Localized Prostate Cancer ◽

Multicenter Phase

Download Full-text

1326: Phase II Trial of Gemcitabine, Paclitaxel, and Cisplatin in Advanced Transitional Cell Carcinoma

The Journal of Urology ◽

10.1016/s0022-5347(18)35471-5 ◽

2005 ◽

Vol 173 (4S) ◽

pp. 360-360

Author(s):

Peter E. Clark ◽

Diana Stindt ◽

M. Craig Hall ◽

Michele Harmon ◽

James F. Lovato ◽

...

Keyword(s):

Transitional Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Transitional Cell

Download Full-text

Experimental Drug Shows Activity Against Advanced Ovarian Cancer in Phase II Trial

Ob Gyn News ◽

10.1016/s0029-7437(07)70576-1 ◽

2007 ◽

Vol 42 (13) ◽

pp. 2

Author(s):

PATRICE WENDLING

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Ovarian Cancer ◽

Experimental Drug

Download Full-text

CNTO 1275 for Psoriasis Holds Steady in Phase II

Skin & Allergy News ◽

10.1016/s0037-6337(06)71375-4 ◽

2006 ◽

Vol 37 (7) ◽

pp. 28

Author(s):

SHERRY BOSCHERT

Keyword(s):

Phase Ii

Download Full-text

Clinical management of patients undergoing biological therapy, with recombinant human interleukin-2 (rhIL-2): Experiences in a phase II study

Clinical Oncology ◽

10.1016/s0936-6555(05)81237-3 ◽

1991 ◽

Vol 3 ◽

pp. 295-295

Keyword(s):

Phase Ii ◽

Clinical Management ◽

Biological Therapy ◽

Phase Ii Study ◽

Interleukin 2

Download Full-text

Safety of Herceptin monotherapy administered on a 3-weekly schedule: Preliminary data from a phase II study in women with HER2-positive metastatic breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(02)80299-4 ◽

2002 ◽

Vol 38 (11) ◽

pp. S95

Author(s):

J Baselga

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Preliminary Data ◽

Phase Ii Study ◽

Metastatic Breast ◽

Weekly Schedule ◽

Her2 Positive

Download Full-text

Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: A Gynecologic Oncology Group study

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70331-2 ◽

2007 ◽

Vol 2007 ◽

pp. 82-83

Author(s):

J.T. Thigpen

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Gynecologic Oncology ◽

Weekly Paclitaxel ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study

Download Full-text

Study of Paclitaxel, Etoposide, and Cisplatin Chemotherapy Combined With Twice-Daily Thoracic Radiotherapy for Patients With Limited-Stage Small-Cell Lung Cancer: A Radiation Therapy Oncology Group 9609 Phase II Study

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70153-2 ◽

2006 ◽

Vol 2006 ◽

pp. 218-219

Author(s):

N.H. Hanna

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Radiation Therapy Oncology Group ◽

Small Cell ◽

Oncology Group ◽

Thoracic Radiotherapy ◽

Small Cell Lung

Download Full-text